Biotech startups in Manchester, United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Imperagen | Manchester | Seed | $6.7M | 2026-05-20 |
| Phagenesis | Manchester | Series D | $42.0M | 2024-03-04 |
| Holiferm | Manchester | Series B | $23.2M | 2023-12-06 |
| Arctic Shores | Manchester | Series B | $7.0M | 2023-01-16 |
| Re:course | Manchester | Seed | $4.3M | 2023-02-02 |
| Elucid mHealth | Manchester | Series A | $1.9M | 2017-09-19 |
6 rows of the CSV in 5 of its 18 columns.
- The 20 biotech startups in Manchester, United Kingdom have raised $471.3M in total.
- 2 of them closed their most recent round in the last 12 months, $6.7M combined.
- The largest of those rounds is Imperagen's $6.7M seed round, dated May 2026.
- Northern Gritstone is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 16 companies (80%).
- 20% were founded in 2020 or later; the median founding year is 2014.
- The most common team size is 1 to 10 employees (45% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
5 of 20| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
| Phagenesis | Phagenesis develops a device that treats dysphagia, a condition that makes swallowing food unsafe. | Biotech | Series D | $42.0M | 2024-03-04 | $71.4M | MedTech Innovator, EQT Life Sciences, Northern Gritstone +2 | 11 to 50 | 2007 |
| Holiferm | Holiferm develops fermentation technology that aims to deliver large economic gains. | Biotech | Series B | $23.2M | 2023-12-06 | Clean Growth Fund, Greater Manchester Combined Authority, ICOS Capital Management +1 | 51 to 100 | 2018 | |
| Re:course | Re:course is a platform where clinicians build practical skills by applying theory immediately. | Biotech | Seed | $4.3M | 2023-02-02 | Praetura Ventures, Par Equity, Northern Gritstone | 11 to 50 | 2018 | |
| Arctic Shores | Arctic Shores provides behavior-based assessments to employers and companies. | Artificial intelligence | Series B | $7.0M | 2023-01-16 | Beringea, Praetura Ventures, Calculus Capital +1 | 51 to 100 | 2013 |
Table 1. Biotech startups in Manchester, United Kingdom: the 5 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 20.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Imperagen | Imperagen is a biotechnology company that researches enzyme engineering, artificial intelligence, and synthetic biology. | Artificial intelligence | Seed | $6.7M | 2026-05-20 | $11.0M | IQ Capital, Northern Gritstone | 11 to 50 | 2021 |
Table 2. Biotech startups in Manchester, United Kingdom: the 1 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Northern Gritstone | Venture capital firm | Leeds, United Kingdom | 3 | 15% | 1 | Imperagen |
| 2 | Praetura Ventures | Venture capital firm | Manchester, United Kingdom | 2 | 10% | ||
| 3 | GM&C Life Sciences Fund | Venture capital firm | Alderley Edge, United Kingdom | 2 | 10% | ||
| 4 | IQ Capital | Venture capital firm | London, United Kingdom | 1 | 5% | 1 | Imperagen |
| 5 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 1 | 5% | ||
| 6 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | 1 | 5% | ||
| 7 | British Patient Capital | Venture capital firm | Sheffield, United Kingdom | 1 | 5% | ||
| 8 | Sectoral Asset Management | Private equity firm | Montréal, Canada | 1 | 5% | ||
| 9 | Rhapsody Venture Partners | Venture capital firm | Cambridge, United States | 1 | 5% | ||
| 10 | Greater Manchester Combined Authority | Government investment office | Manchester, United Kingdom | 1 | 5% | ||
| 11 | Clean Growth Fund | Venture capital firm | London, United Kingdom | 1 | 5% | ||
| 12 | ICOS Capital Management | Startup accelerator | Rotterdam, The Netherlands | 1 | 5% | ||
| 13 | Beringea | Private equity firm | Farmington Hills, United States | 1 | 5% | ||
| 14 | Calculus Capital | Private equity firm | London, United Kingdom | 1 | 5% | ||
| 15 | Candy Ventures | Venture capital firm | Luxembourg | 1 | 5% |
Table 3. Biotech startups in Manchester, United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 16 | 80% | $460.3M |
| Software | 6 | 30% | $14.0M |
| Artificial intelligence | 2 | 10% | $11.0M |
| Hardware | 1 | 5% |
Table 4. Biotech startups in Manchester, United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 2 | 10% | $1.2M |
| Seed | 8 | 40% | $4.3M |
| Series A | 4 | 20% | $2.5M |
| Series B | 3 | 15% | $23.2M |
| Series D+ | 3 | 15% | $42.0M |
Table 5. Biotech startups in Manchester, United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| June 2026 | 1 | 50% | |
| May 2026 | 1 | 50% | $6.7M |
Table 6. Biotech startups in Manchester, United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 2 | 10% | $6.7M |
| 2024 | 3 | 15% | $142.0M |
| 2023 | 4 | 20% | $35.7M |
| 2018 | 3 | 15% | $3.4M |
| 2017 | 2 | 10% | $1.9M |
| 2016 | 2 | 10% |
Table 7. Biotech startups in Manchester, United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 5% |
| 2020 to 2022 | 3 | 15% |
| 2015 to 2019 | 5 | 25% |
| 2010 to 2014 | 6 | 30% |
| Before 2010 | 5 | 25% |
Table 8. Biotech startups in Manchester, United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 9 | 45% |
| 11 to 50 | 8 | 40% |
| 51 to 100 | 2 | 10% |
| 101 to 250 | 1 | 5% |
Table 9. Biotech startups in Manchester, United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Manchester, United Kingdom. On 16 November 2026 that is 20 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 5 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 20 rows: 7 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Manchester, United Kingdom are on the list?
- 20, in the file dated 16 November 2026. 2 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 20 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.